VALZANIA, FRANCO
 Distribuzione geografica
Continente #
NA - Nord America 423
EU - Europa 275
AS - Asia 230
OC - Oceania 17
SA - Sud America 10
AF - Africa 3
Totale 958
Nazione #
US - Stati Uniti d'America 417
IT - Italia 156
SG - Singapore 109
CN - Cina 55
FI - Finlandia 27
HK - Hong Kong 24
ID - Indonesia 22
AU - Australia 15
NL - Olanda 15
GB - Regno Unito 14
DE - Germania 12
BR - Brasile 10
CZ - Repubblica Ceca 7
FR - Francia 7
SE - Svezia 6
ES - Italia 5
IE - Irlanda 5
IN - India 5
PT - Portogallo 5
RU - Federazione Russa 5
CA - Canada 4
KR - Corea 4
LT - Lituania 4
IL - Israele 3
TR - Turchia 3
BE - Belgio 2
GR - Grecia 2
LV - Lettonia 2
MA - Marocco 2
MX - Messico 2
NZ - Nuova Zelanda 2
EG - Egitto 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
PH - Filippine 1
RS - Serbia 1
SA - Arabia Saudita 1
VN - Vietnam 1
Totale 958
Città #
Santa Clara 325
Singapore 87
Hong Kong 24
Helsinki 23
Jakarta 22
Bologna 18
Ashburn 17
Rome 17
New York 13
Parma 10
Munich 9
Rio de Janeiro 8
Sydney 8
Amsterdam 7
Brno 7
Montecchio Emilia 7
Beijing 5
Dublin 5
Modena 5
Moscow 5
Formigine 4
Lappeenranta 4
Shanghai 4
Adelaide 3
Livorno 3
Los Angeles 3
Milan 3
Oxford 3
Romola 3
Varanasi 3
Alexandria 2
Assago 2
Bathgate 2
Blyth 2
Brisbane 2
Brooklyn 2
Brunflo 2
Brussels 2
Calcinaia 2
Casablanca 2
Castegnero 2
Catania 2
Cene 2
Christchurch 2
Coimbra 2
Diyarbakır 2
Florence 2
Genoa 2
Jeonju 2
Kilburn 2
Madrid 2
Maranello 2
McLean 2
Padova 2
Perugia 2
Porto 2
Ramat Gan 2
Reynosa 2
Riga 2
Scandiano 2
Seattle 2
Sissa 2
Thessaloniki 2
Toronto 2
Acton 1
Americana 1
Arezzo 1
Asyut 1
Baicheng 1
Bergamo 1
Bloomington 1
Boa Vista 1
Boardman 1
Brescia 1
Castelnovo di Sotto 1
Changzhou 1
Chennai 1
Chiswick 1
Columbus 1
Dallas 1
Forlì 1
Fort Worth 1
Frankfurt am Main 1
Granada 1
Greenville 1
Gualdo Tadino 1
Ho Chi Minh City 1
Lanzo d'Intelvi 1
London 1
Medesano 1
Melbourne 1
Miami 1
Misterbianco 1
Nagpur 1
New Bedfont 1
Newark 1
Nyköping 1
Ottawa 1
Paris 1
Portland 1
Totale 759
Nome #
Quantitative dopamine transporter imaging assessment in Parkinson’s disease (PD) patients carrying GBA gene mutations compared with Idiopathic PD patients: A case-control study 97
Insights into healthcare professionals’ perceptions and attitudes toward nanotechnological device application: What is the current situation in glioblastoma research? 73
Interplay between speech and gait variables in Parkinson's disease patients treated with subthalamic nucleus deep brain stimulation: A long-term instrumental assessment 71
Vestibular­ and­ saccadic­ abnormalities­ in ­Parkinson's­ disease­ patients: ­Possible ­marker ­of­neurodegenerative­ burdern? 62
Long-term effects of bilateral subthalamic nucleus deep brain stimulation on gait disorders in Parkinson’s disease: a clinical-instrumental study 59
Efficacy and Tolerability of Perampanel in Brain Tumor-Related Epilepsy: A Systematic Review 58
Long-term effects of subthalamic nucleus deep brain stimulation on speech in Parkinson's disease 53
Effect of tauroursodeoxycholic acid on survival and safety in amyotrophic lateral sclerosis: a retrospective population-based cohort study 38
Exploring implication of dysfunctional cellular pathways in Parkinson's disease: Lysosomal-PD and mitochondrial-PD 38
"Somewhere Between an Actual Disease and a Disease": A Grounded Theory Study on Diagnosing Functional Neurological Disorders From a Multi-Informant Perspective 37
Neurosteroid Levels in GBA Mutated and Non-Mutated Parkinson’s Disease: A Possible Factor Influencing Clinical Phenotype? 36
Obsessive-compulsive disorder as a first manifestation of Ataxia with Oculomotor Apraxia type 2 due to a novel mutation of SETX gene 35
Cerebellar mutism syndrome caused by bilateral cerebellar hemorrhage in adults: a case report and review of the literature 32
Recurrent Falls as the Only Clinical Sign of Cortical–Subcortical Myoclonus: A Case Report 26
Longitudinal Neuropsychological Assessment of Symptomatic Edema after Subthalamic Nucleus Deep Brain Stimulation Surgery: A Case Series Study 25
A study on the correlations between acoustic speech variables and bradykinesia in advanced Parkinson's disease 24
Developmental and epileptic encephalopathy in a young Italian woman with a de novo missense variant in the CLCN4 gene: A case report 23
Levodopa responsive asymmetric parkinsonism as clinical presentation of progranulin gene mutation 22
A Case of 18p Chromosomal Deletion Encompassing GNAL in a Patient With Dystonia-Parkinsonism 22
Recent Advances in the Treatment of Genetic Forms of Parkinson’s Disease: Hype or Hope? 21
Vestibular Hypofunction in ARSACS Syndrome: A Possible Pitfall in the Differential Diagnosis of Recessive Cerebellar and Afferent Ataxias. 21
Case Report: Pituitary metastasis as a presenting manifestation of silent gastric cardia adenocarcinoma 20
Factors affecting outcome in ocular myasthenia gravis 20
Speech, Gait, and Vestibular Function in Cerebellar Ataxia with Neuropathy and Vestibular Areflexia Syndrome 18
Just smile or not? A case of isolated smiling tremor 18
Subcortical generalized myoclonus as a presenting symptom of quetiapine overdose 18
To be or not to be: The dilemma over the prognostic role of epilepsy at presentation in patients with glioblastoma – a systematic review and meta-analysis 17
Impact of sex hormones on glioblastoma: Sex-related differences and neuroradiological insights 16
Cerebral amyloid-β deposition, axial features, and cognitive alterations in patients with Parkinson’s disease treated with bilateral STN-DBS: A long-term cohort study 10
Totale 1.010
Categoria #
all - tutte 6.684
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.684


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202340 0 0 0 0 0 0 0 1 4 3 17 15
2023/2024268 18 29 20 32 20 29 25 13 10 10 32 30
2024/2025702 13 12 118 108 257 194 0 0 0 0 0 0
Totale 1.010